Padagis Achieves A US First With Budesonide Foam Launch
Rival To Uceris Rectal Foam Benefits From 180 Days Of CGT Exclusivity
Padagis has launched budesonide 2mg rectal foam, the first US generic version of Uceris, with 180 days of competitive generic therapy exclusivity.
